Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Paclitaxel × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 35 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Ovarian Epithelial 4 Breast Neoplasms 4 Uveal Melanoma 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Sezary Syndrome 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2

Interventions

pembrolizumab 2 nintedanib 1 dabrafenib 1 Vitamin D 1 Surveys and Questionnaires 1 Paclitaxel 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Cholecalciferol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02308553 2020-10-14

NIPAWILMA

University Hospital, Essen

Phase 1/2 Completed

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡